James R Fuller, Kevin E Knockenhauer, Nina C Leksa, Robert T Peters, Joseph D Batchelor. Blood 2021
Times Cited: 3
Times Cited: 3
Times Cited
Times Co-cited
Similarity
BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice.
Ekta Seth Chhabra, Tongyao Liu, John Kulman, Susannah Patarroyo-White, Buyue Yang, Qi Lu, Douglas Drager, Nancy Moore, Jiayun Liu, Amy M Holthaus,[...]. Blood 2020
Ekta Seth Chhabra, Tongyao Liu, John Kulman, Susannah Patarroyo-White, Buyue Yang, Qi Lu, Douglas Drager, Nancy Moore, Jiayun Liu, Amy M Holthaus,[...]. Blood 2020
66
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.
Steven W Pipe, Robert R Montgomery, Kathleen P Pratt, Peter J Lenting, David Lillicrap. Blood 2016
Steven W Pipe, Robert R Montgomery, Kathleen P Pratt, Peter J Lenting, David Lillicrap. Blood 2016
66
Assembly Mechanism of Mucin and von Willebrand Factor Polymers.
Gabriel Javitt, Lev Khmelnitsky, Lis Albert, Lavi Shlomo Bigman, Nadav Elad, David Morgenstern, Tal Ilani, Yaakov Levy, Ron Diskin, Deborah Fass. Cell 2020
Gabriel Javitt, Lev Khmelnitsky, Lis Albert, Lavi Shlomo Bigman, Nadav Elad, David Morgenstern, Tal Ilani, Yaakov Levy, Ron Diskin, Deborah Fass. Cell 2020
33
Interaction Between the a3 Region of Factor VIII and the TIL'E' Domains of the von Willebrand Factor.
Lisbeth Dagil, Kathrin S Troelsen, Gert Bolt, Lars Thim, Bo Wu, Xin Zhao, Edward G D Tuddenham, Thomas E Nielsen, David A Tanner, Johan H Faber,[...]. Biophys J 2019
Lisbeth Dagil, Kathrin S Troelsen, Gert Bolt, Lars Thim, Bo Wu, Xin Zhao, Edward G D Tuddenham, Thomas E Nielsen, David A Tanner, Johan H Faber,[...]. Biophys J 2019
33
Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
Hans Ulrichts, Miklós Udvardy, Peter J Lenting, Inge Pareyn, Nele Vandeputte, Karen Vanhoorelbeke, Hans Deckmyn. J Biol Chem 2006
Hans Ulrichts, Miklós Udvardy, Peter J Lenting, Inge Pareyn, Nele Vandeputte, Karen Vanhoorelbeke, Hans Deckmyn. J Biol Chem 2006
33
The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis.
Xianchi Dong, Nina C Leksa, Ekta Seth Chhabra, Joseph W Arndt, Qi Lu, Kevin E Knockenhauer, Robert T Peters, Timothy A Springer. Blood 2019
Xianchi Dong, Nina C Leksa, Ekta Seth Chhabra, Joseph W Arndt, Qi Lu, Kevin E Knockenhauer, Robert T Peters, Timothy A Springer. Blood 2019
33
Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII.
Andrew Yee, Austin N Oleskie, Anne M Dosey, Colin A Kretz, Robert D Gildersleeve, Somnath Dutta, Min Su, David Ginsburg, Georgios Skiniotis. Blood 2015
Andrew Yee, Austin N Oleskie, Anne M Dosey, Colin A Kretz, Robert D Gildersleeve, Somnath Dutta, Min Su, David Ginsburg, Georgios Skiniotis. Blood 2015
33
Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry.
Po-Lin Chiu, George M Bou-Assaf, Ekta Seth Chhabra, Melissa G Chambers, Robert T Peters, John D Kulman, Thomas Walz. Blood 2015
Po-Lin Chiu, George M Bou-Assaf, Ekta Seth Chhabra, Melissa G Chambers, Robert T Peters, John D Kulman, Thomas Walz. Blood 2015
33
Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice.
Nadine Vollack-Hesse, Olga Oleshko, Sonja Werwitzke, Barbara Solecka-Witulska, Christoph Kannicht, Andreas Tiede. Blood 2021
Nadine Vollack-Hesse, Olga Oleshko, Sonja Werwitzke, Barbara Solecka-Witulska, Christoph Kannicht, Andreas Tiede. Blood 2021
33
Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
R Titapiwatanakun, C Moir, R K Pruthi, P L Stavlo, K A Schmidt, V Rodriguez. Haemophilia 2009
R Titapiwatanakun, C Moir, R K Pruthi, P L Stavlo, K A Schmidt, V Rodriguez. Haemophilia 2009
33
Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
P Lind, K Larsson, J Spira, M Sydow-Bäckman, A Almstedt, E Gray, H Sandberg. Eur J Biochem 1995
P Lind, K Larsson, J Spira, M Sydow-Bäckman, A Almstedt, E Gray, H Sandberg. Eur J Biochem 1995
33
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Marilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, Brenda Riske, Michele R Hacker, Ray Kilcoyne, J David Ingram, Michael L Manco-Johnson, Sharon Funk, Linda Jacobson,[...]. N Engl J Med 2007
Marilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, Brenda Riske, Michele R Hacker, Ray Kilcoyne, J David Ingram, Michael L Manco-Johnson, Sharon Funk, Linda Jacobson,[...]. N Engl J Med 2007
33
Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety.
Johnny Mahlangu, Howard Levy, Marina V Kosinova, Heghine Khachatryan, Bartosz Korczowski, Levani Makhaldiani, Genadi Iosava, Martin Lee, Frank Del Greco. Res Pract Thromb Haemost 2021
Johnny Mahlangu, Howard Levy, Marina V Kosinova, Heghine Khachatryan, Bartosz Korczowski, Levani Makhaldiani, Genadi Iosava, Martin Lee, Frank Del Greco. Res Pract Thromb Haemost 2021
100
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).
A Gringeri, B Lundin, S von Mackensen, L Mantovani, P M Mannucci. J Thromb Haemost 2011
A Gringeri, B Lundin, S von Mackensen, L Mantovani, P M Mannucci. J Thromb Haemost 2011
33
Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8-GP) and development of a human pharmacokinetic prediction model.
F Rode, K Almholt, M Petersen, M Kreilgaard, M Kjalke, D M Karpf, A V Groth, P B Johansen, L F Larsen, M Loftager,[...]. J Thromb Haemost 2018
F Rode, K Almholt, M Petersen, M Kreilgaard, M Kjalke, D M Karpf, A V Groth, P B Johansen, L F Larsen, M Loftager,[...]. J Thromb Haemost 2018
33
Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study.
Johannes Oldenburg, Charles R M Hay, Víctor Jiménez-Yuste, Flora Peyvandi, Jean-François Schved, Johan Szamosi, Bent Winding, Stefan Lethagen. BMJ Open 2019
Johannes Oldenburg, Charles R M Hay, Víctor Jiménez-Yuste, Flora Peyvandi, Jean-François Schved, Johan Szamosi, Bent Winding, Stefan Lethagen. BMJ Open 2019
33
Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration.
A Supersaxo, W R Hein, H Steffen. Pharm Res 1990
A Supersaxo, W R Hein, H Steffen. Pharm Res 1990
33
Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1).
Robert Klamroth, Clemens Feistritzer, Ute Friedrich, Steven R Lentz, Kirsten Reichwald, Marek Zak, Pratima Chowdary. J Thromb Haemost 2020
Robert Klamroth, Clemens Feistritzer, Ute Friedrich, Steven R Lentz, Kirsten Reichwald, Marek Zak, Pratima Chowdary. J Thromb Haemost 2020
33
FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasis.
Marie Cadé, Javier Muñoz-Garcia, Antoine Babuty, Marc Fouassier, Marie-Francoise Heymann, Paul E Monahan, Dominique Heymann. Drug Discov Today 2022
Marie Cadé, Javier Muñoz-Garcia, Antoine Babuty, Marc Fouassier, Marie-Francoise Heymann, Paul E Monahan, Dominique Heymann. Drug Discov Today 2022
50
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.
Barbara A Konkle, Amy D Shapiro, Doris V Quon, Janice M Staber, Roshni Kulkarni, Margaret V Ragni, Ekta S Chhabra, Stacey Poloskey, Kara Rice, Suresh Katragadda,[...]. N Engl J Med 2020
Barbara A Konkle, Amy D Shapiro, Doris V Quon, Janice M Staber, Roshni Kulkarni, Margaret V Ragni, Ekta S Chhabra, Stacey Poloskey, Kara Rice, Suresh Katragadda,[...]. N Engl J Med 2020
33
Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
33
Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities.
Beate Bittner, Wolfgang Richter, Johannes Schmidt. BioDrugs 2018
Beate Bittner, Wolfgang Richter, Johannes Schmidt. BioDrugs 2018
33
Emicizumab: Review of the literature and critical appraisal.
E Carlos Rodriguez-Merchan, Leonard A Valentino. Haemophilia 2019
E Carlos Rodriguez-Merchan, Leonard A Valentino. Haemophilia 2019
33
Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice.
Q Shi, E L Kuether, J A Schroeder, S A Fahs, R R Montgomery. Haemophilia 2012
Q Shi, E L Kuether, J A Schroeder, S A Fahs, R R Montgomery. Haemophilia 2012
33
Recombinant factor VIII SQ--stability of VIII: C in homogenates from porcine, monkey and human subcutaneous tissue.
A Fatouros, Y Lidén, B Sjöström. J Pharm Pharmacol 2000
A Fatouros, Y Lidén, B Sjöström. J Pharm Pharmacol 2000
33
The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing.
Maria Elisa Mancuso, Johnny N Mahlangu, Steven W Pipe. Lancet 2021
Maria Elisa Mancuso, Johnny N Mahlangu, Steven W Pipe. Lancet 2021
33
A fixed 'single vial' dose of subcutaneous desmopressin (DDAVP) produces adequate biologic responses for persons with mild haemophilia A.
Joseph Noye, John A Rowell, Beryl Zeissink, Alex Connolly, Jane A Mason. Haemophilia 2021
Joseph Noye, John A Rowell, Beryl Zeissink, Alex Connolly, Jane A Mason. Haemophilia 2021
100
Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries.
Alfonso Iorio, Jeffrey S Stonebraker, Hervé Chambost, Michael Makris, Donna Coffin, Christine Herr, Federico Germini. Ann Intern Med 2019
Alfonso Iorio, Jeffrey S Stonebraker, Hervé Chambost, Michael Makris, Donna Coffin, Christine Herr, Federico Germini. Ann Intern Med 2019
33
von Willebrand factor antigen latex immunoassays are affected to a different extent by rheumatoid factor.
Agota Schlammadinger, Karen Vanhoorelbeke, Pal Laszlo, Zsuzsa Bereczky, Laszlo Muszbek, Hans Deckmyn, Zoltan Boda. Clin Appl Thromb Hemost 2006
Agota Schlammadinger, Karen Vanhoorelbeke, Pal Laszlo, Zsuzsa Bereczky, Laszlo Muszbek, Hans Deckmyn, Zoltan Boda. Clin Appl Thromb Hemost 2006
33
Clinical problem-solving. A bloody mystery.
Adam Cuker, Jean M Connors, Joel T Katz, Bruce D Levy, Joseph Loscalzo. N Engl J Med 2009
Adam Cuker, Jean M Connors, Joel T Katz, Bruce D Levy, Joseph Loscalzo. N Engl J Med 2009
33
The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.
Soracha E Ward, Jamie M O'Sullivan, James S O'Donnell. Blood 2020
Soracha E Ward, Jamie M O'Sullivan, James S O'Donnell. Blood 2020
33
Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors.
Ana Kasirer-Friede, Maria Rita Cozzi, Mario Mazzucato, Luigi De Marco, Zaverio M Ruggeri, Sanford J Shattil. Blood 2004
Ana Kasirer-Friede, Maria Rita Cozzi, Mario Mazzucato, Luigi De Marco, Zaverio M Ruggeri, Sanford J Shattil. Blood 2004
33
Platelet alpha-granules: basic biology and clinical correlates.
Price Blair, Robert Flaumenhaft. Blood Rev 2009
Price Blair, Robert Flaumenhaft. Blood Rev 2009
33
Von Willebrand disease type 2N: An update.
Omid Seidizadeh, Flora Peyvandi, Pier Mannuccio Mannucci. J Thromb Haemost 2021
Omid Seidizadeh, Flora Peyvandi, Pier Mannuccio Mannucci. J Thromb Haemost 2021
33
Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women.
C H Miller, A Dilley, L Richardson, W C Hooper, B L Evatt. Am J Hematol 2001
C H Miller, A Dilley, L Richardson, W C Hooper, B L Evatt. Am J Hematol 2001
33
Sequence and structure relationships within von Willebrand factor.
Yan-Feng Zhou, Edward T Eng, Jieqing Zhu, Chafen Lu, Thomas Walz, Timothy A Springer. Blood 2012
Yan-Feng Zhou, Edward T Eng, Jieqing Zhu, Chafen Lu, Thomas Walz, Timothy A Springer. Blood 2012
33
ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.
F Rodeghiero, A Tosetto, T Abshire, D M Arnold, B Coller, P James, C Neunert, D Lillicrap. J Thromb Haemost 2010
F Rodeghiero, A Tosetto, T Abshire, D M Arnold, B Coller, P James, C Neunert, D Lillicrap. J Thromb Haemost 2010
33
Automated assays for von Willebrand factor activity.
Russell A Higgins, Andrew J Goodwin. Am J Hematol 2019
Russell A Higgins, Andrew J Goodwin. Am J Hematol 2019
33
33
Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay.
D Chen, J I Tange, B J Meyers, R K Pruthi, W L Nichols, J A Heit. J Thromb Haemost 2011
D Chen, J I Tange, B J Meyers, R K Pruthi, W L Nichols, J A Heit. J Thromb Haemost 2011
33
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.
Paula D James, Nathan T Connell, Barbara Ameer, Jorge Di Paola, Jeroen Eikenboom, Nicolas Giraud, Sandra Haberichter, Vicki Jacobs-Pratt, Barbara Konkle, Claire McLintock,[...]. Blood Adv 2021
Paula D James, Nathan T Connell, Barbara Ameer, Jorge Di Paola, Jeroen Eikenboom, Nicolas Giraud, Sandra Haberichter, Vicki Jacobs-Pratt, Barbara Konkle, Claire McLintock,[...]. Blood Adv 2021
33
Weibel-Palade bodies at a glance.
Jessica J McCormack, Mafalda Lopes da Silva, Francesco Ferraro, Francesca Patella, Daniel F Cutler. J Cell Sci 2017
Jessica J McCormack, Mafalda Lopes da Silva, Francesco Ferraro, Francesca Patella, Daniel F Cutler. J Cell Sci 2017
33
Clinically relevant differences between assays for von Willebrand factor activity.
J Boender, J Eikenboom, J G van der Bom, K Meijer, J de Meris, K Fijnvandraat, M H Cnossen, B A P Laros-van Gorkom, W L van Heerde, E P Mauser-Bunschoten,[...]. J Thromb Haemost 2018
J Boender, J Eikenboom, J G van der Bom, K Meijer, J de Meris, K Fijnvandraat, M H Cnossen, B A P Laros-van Gorkom, W L van Heerde, E P Mauser-Bunschoten,[...]. J Thromb Haemost 2018
33
Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
Dieter Klarmann, Christine Eggert, Christof Geisen, Sabine Becker, Erhard Seifried, Thomas Klingebiel, Wolfhart Kreuz. Transfusion 2010
Dieter Klarmann, Christine Eggert, Christof Geisen, Sabine Becker, Erhard Seifried, Thomas Klingebiel, Wolfhart Kreuz. Transfusion 2010
33
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.